Abstract
Regulatory or suppressive receptors on plasmacytoid dendritic cells (PDCs) are an attractive therapeutic target in systemic lupus erythematosus (SLE), given the role type I interferon (IFN) plays in this disease....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have